HC Deb 01 July 1996 vol 280 c337W
Mr. Flynn

To ask the Secretary of State for Health if he will make it his policy to ensure that cannabis or further derivatives of cannabis are available to those suffering from multiple sclerosis, cerebral palsy, glaucoma and the effects of chemotherapy. [34894]

Mr. Bowis

Nabilone, a synthetic cannabinoid, is already licensed for use in the treatment of certain conditions. Should any company wish to apply for a licence for medicines derived from cannabis, the Medicines Control Agency would consider this on the basis of the product's quality, safety and efficacy.

Back to